Enhanced phosphorylation of Na+ -Cl- co-transporter in experimental metabolic syndrome: Role of insulin

Radko Komers, Shaunessy Rogers, Terry Oyamat, Bei Xu, Chao-Ling Yang, James (Jim) McCormick, David Ellison

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

In the present study, we investigated the activity of the thiazide-sensitive NCC (Na+ -Cl- co- transporter) in experimental metabolic syndrome and the role of insulin in NCC activation. Renal responses to the NCC inhibitor HCTZ (hydrochlorothiazide), as a measure of NCC activity in vivo, were studied in 12-week-old ZO (Zucker obese) rats, a model of the metabolic syndrome, and in ZL (Zucker lean) control animals, together with renal NCC expression and molecular markers of NCC activity, such as localization and phosphorylation. Effects of insulin were studied further in mammalian cell lines with inducible and endogenous expression of this molecule. ZO rats displayed marked hyperinsulinaemia, but no differences in plasma aldosterone, compared with ZL rats. In ZO rats, natriuretic and diuretic responses to NCC inhibition with HCTZ were enhanced compared with ZL rats, and were associated with a decrease in BP (blood pressure). ZO rats displayed enhanced Thr53 NCC phosphorylation and predominant membrane localization of both total and phosphorylated NCC, together with a different profile in expression of SPAK (Ste20-related proline/alanine-rich kinase) isoforms, and lower expression of WNK4. In vitro, insulin induced NCC phosphorylation, which was blocked by a PI3K (phosphoinositide 3-kinase) inhibitor. Insulin-induced reduction in WNK4 expression was also observed, but delayed compared with the time course of NCC phosphorylation. In summary, we report increased NCC activity in hyperinsulinaemic rodents in conjunction with the SPAK expression profile consistent with NCC activation and reduced WNK4, as well as an ability of insulin to induce NCC stimulatory phosphorylation in vitro. Together, these findings indicate that hyperinsulinaemia is an important driving force of NCC activity in the metabolic syndrome with possible consequences for BP regulation.

Original languageEnglish (US)
Pages (from-to)635-647
Number of pages13
JournalClinical Science
Volume123
Issue number11
DOIs
StatePublished - Dec 2012

Fingerprint

Symporters
Phosphorylation
Insulin
Zucker Rats
Hydrochlorothiazide
Hyperinsulinism
Blood Pressure
Thiazides
Kidney
1-Phosphatidylinositol 4-Kinase
Aldosterone

Keywords

  • Insulin
  • Metabolic syndrome
  • Thiazide-sensitive sodium-chloride co-transporter
  • WNK4
  • Zucker obese rat

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Enhanced phosphorylation of Na+ -Cl- co-transporter in experimental metabolic syndrome : Role of insulin. / Komers, Radko; Rogers, Shaunessy; Oyamat, Terry; Xu, Bei; Yang, Chao-Ling; McCormick, James (Jim); Ellison, David.

In: Clinical Science, Vol. 123, No. 11, 12.2012, p. 635-647.

Research output: Contribution to journalArticle

@article{33af1930d16140c982df8e4369b98440,
title = "Enhanced phosphorylation of Na+ -Cl- co-transporter in experimental metabolic syndrome: Role of insulin",
abstract = "In the present study, we investigated the activity of the thiazide-sensitive NCC (Na+ -Cl- co- transporter) in experimental metabolic syndrome and the role of insulin in NCC activation. Renal responses to the NCC inhibitor HCTZ (hydrochlorothiazide), as a measure of NCC activity in vivo, were studied in 12-week-old ZO (Zucker obese) rats, a model of the metabolic syndrome, and in ZL (Zucker lean) control animals, together with renal NCC expression and molecular markers of NCC activity, such as localization and phosphorylation. Effects of insulin were studied further in mammalian cell lines with inducible and endogenous expression of this molecule. ZO rats displayed marked hyperinsulinaemia, but no differences in plasma aldosterone, compared with ZL rats. In ZO rats, natriuretic and diuretic responses to NCC inhibition with HCTZ were enhanced compared with ZL rats, and were associated with a decrease in BP (blood pressure). ZO rats displayed enhanced Thr53 NCC phosphorylation and predominant membrane localization of both total and phosphorylated NCC, together with a different profile in expression of SPAK (Ste20-related proline/alanine-rich kinase) isoforms, and lower expression of WNK4. In vitro, insulin induced NCC phosphorylation, which was blocked by a PI3K (phosphoinositide 3-kinase) inhibitor. Insulin-induced reduction in WNK4 expression was also observed, but delayed compared with the time course of NCC phosphorylation. In summary, we report increased NCC activity in hyperinsulinaemic rodents in conjunction with the SPAK expression profile consistent with NCC activation and reduced WNK4, as well as an ability of insulin to induce NCC stimulatory phosphorylation in vitro. Together, these findings indicate that hyperinsulinaemia is an important driving force of NCC activity in the metabolic syndrome with possible consequences for BP regulation.",
keywords = "Insulin, Metabolic syndrome, Thiazide-sensitive sodium-chloride co-transporter, WNK4, Zucker obese rat",
author = "Radko Komers and Shaunessy Rogers and Terry Oyamat and Bei Xu and Chao-Ling Yang and McCormick, {James (Jim)} and David Ellison",
year = "2012",
month = "12",
doi = "10.1042/CS20120003",
language = "English (US)",
volume = "123",
pages = "635--647",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "11",

}

TY - JOUR

T1 - Enhanced phosphorylation of Na+ -Cl- co-transporter in experimental metabolic syndrome

T2 - Role of insulin

AU - Komers, Radko

AU - Rogers, Shaunessy

AU - Oyamat, Terry

AU - Xu, Bei

AU - Yang, Chao-Ling

AU - McCormick, James (Jim)

AU - Ellison, David

PY - 2012/12

Y1 - 2012/12

N2 - In the present study, we investigated the activity of the thiazide-sensitive NCC (Na+ -Cl- co- transporter) in experimental metabolic syndrome and the role of insulin in NCC activation. Renal responses to the NCC inhibitor HCTZ (hydrochlorothiazide), as a measure of NCC activity in vivo, were studied in 12-week-old ZO (Zucker obese) rats, a model of the metabolic syndrome, and in ZL (Zucker lean) control animals, together with renal NCC expression and molecular markers of NCC activity, such as localization and phosphorylation. Effects of insulin were studied further in mammalian cell lines with inducible and endogenous expression of this molecule. ZO rats displayed marked hyperinsulinaemia, but no differences in plasma aldosterone, compared with ZL rats. In ZO rats, natriuretic and diuretic responses to NCC inhibition with HCTZ were enhanced compared with ZL rats, and were associated with a decrease in BP (blood pressure). ZO rats displayed enhanced Thr53 NCC phosphorylation and predominant membrane localization of both total and phosphorylated NCC, together with a different profile in expression of SPAK (Ste20-related proline/alanine-rich kinase) isoforms, and lower expression of WNK4. In vitro, insulin induced NCC phosphorylation, which was blocked by a PI3K (phosphoinositide 3-kinase) inhibitor. Insulin-induced reduction in WNK4 expression was also observed, but delayed compared with the time course of NCC phosphorylation. In summary, we report increased NCC activity in hyperinsulinaemic rodents in conjunction with the SPAK expression profile consistent with NCC activation and reduced WNK4, as well as an ability of insulin to induce NCC stimulatory phosphorylation in vitro. Together, these findings indicate that hyperinsulinaemia is an important driving force of NCC activity in the metabolic syndrome with possible consequences for BP regulation.

AB - In the present study, we investigated the activity of the thiazide-sensitive NCC (Na+ -Cl- co- transporter) in experimental metabolic syndrome and the role of insulin in NCC activation. Renal responses to the NCC inhibitor HCTZ (hydrochlorothiazide), as a measure of NCC activity in vivo, were studied in 12-week-old ZO (Zucker obese) rats, a model of the metabolic syndrome, and in ZL (Zucker lean) control animals, together with renal NCC expression and molecular markers of NCC activity, such as localization and phosphorylation. Effects of insulin were studied further in mammalian cell lines with inducible and endogenous expression of this molecule. ZO rats displayed marked hyperinsulinaemia, but no differences in plasma aldosterone, compared with ZL rats. In ZO rats, natriuretic and diuretic responses to NCC inhibition with HCTZ were enhanced compared with ZL rats, and were associated with a decrease in BP (blood pressure). ZO rats displayed enhanced Thr53 NCC phosphorylation and predominant membrane localization of both total and phosphorylated NCC, together with a different profile in expression of SPAK (Ste20-related proline/alanine-rich kinase) isoforms, and lower expression of WNK4. In vitro, insulin induced NCC phosphorylation, which was blocked by a PI3K (phosphoinositide 3-kinase) inhibitor. Insulin-induced reduction in WNK4 expression was also observed, but delayed compared with the time course of NCC phosphorylation. In summary, we report increased NCC activity in hyperinsulinaemic rodents in conjunction with the SPAK expression profile consistent with NCC activation and reduced WNK4, as well as an ability of insulin to induce NCC stimulatory phosphorylation in vitro. Together, these findings indicate that hyperinsulinaemia is an important driving force of NCC activity in the metabolic syndrome with possible consequences for BP regulation.

KW - Insulin

KW - Metabolic syndrome

KW - Thiazide-sensitive sodium-chloride co-transporter

KW - WNK4

KW - Zucker obese rat

UR - http://www.scopus.com/inward/record.url?scp=84866547191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866547191&partnerID=8YFLogxK

U2 - 10.1042/CS20120003

DO - 10.1042/CS20120003

M3 - Article

C2 - 22651238

AN - SCOPUS:84866547191

VL - 123

SP - 635

EP - 647

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 11

ER -